Peter S. Knight is Director at PAR PHARMACEUTICAL COMPANIES, INC. (PRX). They have made 5 open-market trades across 2 companies since 2007, most recently 2024-07-01.
CIK 0001189792
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $45K since 2007, against 4 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| MRX | SELL | 2012-08-23 | 2012-08-27 | $32.16 | $113K | +2.8% | +2.3% | +2.3% |
| PRX | SELL | 2012-03-19 | 2012-03-21 | $37.02 | $278K | N/A | N/A | N/A |
| PRX | SELL | 2011-12-15 | 2011-12-19 | $32.51 | $81K | N/A | N/A | N/A |
| MRX | SELL | 2011-05-19 | 2011-05-23 | $37.09 | $1.1M | +2.8% | +2.3% | +2.3% |
| PRX | BUY | 2007-10-25 | 2007-10-26 | $18.09 | $45K | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.